Gardasil can help prevent cervical cancer, genital warts, and other conditions caused by certain types of human papillomavirus. The vaccine, which is given as a series of three injections, does not protect against all types of HPV; however, it does protect against four of the most common types. Gardasil has been approved for use in girls and women age 9 to 26, and may also be used to prevent genital warts in boys and men age 9 to 26.
What Is Gardasil?Gardasil® (Quadrivalent Human Papillomavirus [Types 6, 11, 16, and 18] Recombinant Vaccine) is a vaccine that has been licensed to prevent cervical cancer, vulvar and vaginal cancer, genital warts, and various precancerous genital lesions caused by certain types of human papillomavirus (HPV) in girls and women age 9 to 26. This vaccine is also approved to prevent genital warts in boys and men age 9 to 26 years of age.
Recently, Gardasil was also approved to prevent anal cancer and precancerous anal lesions in males and females age 9 to 26 years.
Thimerosal Content and Other ConcernsGardasil does not contain thimerosal (a mercury-containing preservative). Individuals who are concerned about exposure to thimerosal can be confident that this vaccine has no thimerosal (not even trace amounts). Some people are concerned about aluminum content of vaccines; Gardasil contains 225 mcg (0.225 mg) of aluminum per dose.
This vaccine is not made from human fetal components or animal components, as some vaccines are.
Who Makes It?Gardasil is manufactured by Merck & Co., Inc.